Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Monday, December 6, 2010 - 12:20
in Health & Medicine
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and...